Medicina
Departamento
University of Utah
Salt Lake City, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Utah (29)
2023
-
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD
Journal of the American Society of Nephrology : JASN, Vol. 34, Núm. 6, pp. 955-968
2022
-
Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)
Journal of Allergy and Clinical Immunology, Vol. 149, Núm. 2, pp. 659-670
-
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Scientific Data, Vol. 9, Núm. 1
-
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin
Clinical Genitourinary Cancer, Vol. 20, Núm. 2, pp. 165-175
2021
-
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors
European urology oncology, Vol. 4, Núm. 3, pp. 464-472
-
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis
American Journal of Kidney Diseases, Vol. 78, Núm. 3, pp. 340-349.e1
-
Electrocardiographic Imaging for Atrial Fibrillation: A Perspective From Computer Models and Animal Experiments to Clinical Value
Frontiers in Physiology, Vol. 12
-
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients
International Journal of Cancer, Vol. 149, Núm. 2, pp. 327-336
-
Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study
Journal of Psychosomatic Research, Vol. 140
-
Nomenclature in nephrology: preserving ‘renal’ and ‘nephro' in the glossary of kidney health and disease
Journal of Nephrology, Vol. 34, Núm. 3, pp. 639-648
2019
-
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 2, pp. 128-139
-
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
Human Mutation, Vol. 40, Núm. 9, pp. 1557-1578
-
Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4)
Nature Communications
-
Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer
Breast Cancer Research and Treatment, Vol. 175, Núm. 1, pp. 129-139
-
Shared heritability and functional enrichment across six solid cancers
Nature Communications, Vol. 10, Núm. 1
2018
-
Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort
Clinical and Experimental Rheumatology, Vol. 36, pp. S53-S60
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204
-
Randomized feasibility trial of the Scleroderma patient-centered intervention network hand exercise program (SPIN-HAND): Study protocol
Journal of Scleroderma and Related Disorders, Vol. 3, Núm. 1, pp. 91-97
-
Rivaroxaban for thromboprophylaxis after hospitalization for medical illness
New England Journal of Medicine, Vol. 379, Núm. 12, pp. 1118-1127
-
The scleroderma patient-centered intervention network cohort: Baseline clinical features and comparison with other large scleroderma cohorts
Rheumatology (United Kingdom), Vol. 57, Núm. 9, pp. 1623-1631